
Sign up to save your podcasts
Or
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Ian Bruce, from the University of Manchester in the UK. Dr Bruce discusses the time to onset of clinical response to Anifrolumab in patients with Systemic Lupus Erythematosus. The episode delves into pooled data from two significant Phase III trials, TULIP-1 and TULIP-2, offering listeners a deep understanding of the effectiveness and timeline of Anifrolumab treatment.
Read the article: http://dx.doi.org/10.1136/lupus-2022-000761
4
1515 ratings
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Ian Bruce, from the University of Manchester in the UK. Dr Bruce discusses the time to onset of clinical response to Anifrolumab in patients with Systemic Lupus Erythematosus. The episode delves into pooled data from two significant Phase III trials, TULIP-1 and TULIP-2, offering listeners a deep understanding of the effectiveness and timeline of Anifrolumab treatment.
Read the article: http://dx.doi.org/10.1136/lupus-2022-000761
39 Listeners
5 Listeners
48 Listeners
7 Listeners
4 Listeners
3 Listeners
1 Listeners
3 Listeners
10 Listeners
40 Listeners
7,250 Listeners
14 Listeners
1 Listeners
34 Listeners
0 Listeners
6 Listeners
481 Listeners
12,532 Listeners
3,326 Listeners
3 Listeners
33 Listeners
1,094 Listeners
9,216 Listeners
548 Listeners
133 Listeners
23 Listeners
30 Listeners
363 Listeners
22 Listeners
42 Listeners
2 Listeners
0 Listeners
0 Listeners
0 Listeners